131 related articles for article (PubMed ID: 14679277)
1. A promising step forward in psoriasis therapy.
Stern RS
JAMA; 2003 Dec; 290(23):3133-5. PubMed ID: 14679277
[No Abstract] [Full Text] [Related]
2. Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial.
Reich K; Ortonne JP; Kerkmann U; Wang Y; Saurat JH; Papp K; Langley R; Griffiths CE
Dermatology; 2010; 221(2):172-8. PubMed ID: 20628238
[TBL] [Abstract][Full Text] [Related]
3. Ustekinumab (Stelara) for psoriasis.
Med Lett Drugs Ther; 2010 Jan; 52(1330):7-8. PubMed ID: 20208473
[No Abstract] [Full Text] [Related]
4. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.
Takahashi MD; Castro LG; Romiti R
Br J Dermatol; 2007 Oct; 157(4):828-31. PubMed ID: 17711530
[No Abstract] [Full Text] [Related]
5. Marked improvement in nail psoriasis during treatment with adalimumab.
Irla N; Yawalkar N
Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
[TBL] [Abstract][Full Text] [Related]
6. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
Heikkilä H; Ranki A; Cajanus S; Karvonen SL
Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
[No Abstract] [Full Text] [Related]
7. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
[TBL] [Abstract][Full Text] [Related]
8. Guselkumab (Tremfya) for psoriasis.
Med Lett Drugs Ther; 2017 Nov; 59(1533):179-180. PubMed ID: 29125591
[No Abstract] [Full Text] [Related]
9. Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.
Böhner A; Roenneberg S; Eyerich K; Eberlein B; Biedermann T
JAMA Dermatol; 2016 Apr; 152(4):482-4. PubMed ID: 26650014
[No Abstract] [Full Text] [Related]
10. Misunderstandings.
Feldman SR
J Dermatolog Treat; 2007; 18(1):4. PubMed ID: 17365258
[No Abstract] [Full Text] [Related]
11. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab.
Bartke U; Venten I; Kreuter A; Gubbay S; Altmeyer P; Brockmeyer NH
Br J Dermatol; 2004 Apr; 150(4):784-6. PubMed ID: 15099388
[No Abstract] [Full Text] [Related]
12. Advances in psoriasis treatment.
Schön MP
Lancet; 2005 Oct 15-21; 366(9494):1333-5. PubMed ID: 16226595
[No Abstract] [Full Text] [Related]
13. Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies.
Castiñeiras I; Fernández-Diaz L; Juárez Y; Lueiro M
J Dermatol; 2012 Aug; 39(8):730-1. PubMed ID: 22364316
[No Abstract] [Full Text] [Related]
14. Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies.
Rallis E; Verros CD
Dermatol Online J; 2011 Apr; 17(4):14. PubMed ID: 21549089
[No Abstract] [Full Text] [Related]
15. Tattoo sites and psoriasis.
Smith SF; Feldman SR
J Drugs Dermatol; 2011 Oct; 10(10):1199-200. PubMed ID: 21968672
[TBL] [Abstract][Full Text] [Related]
16. [Patient education. Information letter on treatment of psoriasis with infliximab (Remicade)].
Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
Ann Dermatol Venereol; 2011 Dec; 138(12):865-7. PubMed ID: 22137633
[No Abstract] [Full Text] [Related]
17. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
Skrabl-Baumgartner A; Weger W; Salmhofer W; Jahnel J
Pediatr Dermatol; 2015; 32(1):e13-4. PubMed ID: 25644044
[TBL] [Abstract][Full Text] [Related]
18. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate.
Warren RB; Brown BC; Carmichael AJ; Griffiths CE
Clin Exp Dermatol; 2009 Apr; 34(3):415-6. PubMed ID: 19120390
[No Abstract] [Full Text] [Related]
19. [Patient education. Information letter on treatment of psoriasis with ustekinumab (Stelara)].
Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
Ann Dermatol Venereol; 2011 Dec; 138(12):874-5. PubMed ID: 22137636
[No Abstract] [Full Text] [Related]
20. Increased CCL22 expression in psoriatic skin predicts a good response to infliximab therapy.
Kusumoto S; Kajihara I; Nagamoto E; Makino K; Ichihara A; Aoi J; Johno T; Makino T; Fukushima S; Jinnin M; Ihn H
Br J Dermatol; 2014 Nov; 171(5):1259-61. PubMed ID: 24804833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
